Bonesupport: First impressions of Q4 report - Redeye

Redeye provides its initial take on BONESUPPORT’s Q4 report and expects a positive reaction of c.5% in the stock. We are encouraged by the demonstrated continuous sales growth of 15% (21% in constant exchange rates) in a quarter where elective surgeries were severely halted towards the end.

Länk till analysen i sin helhet: https://www.redeye.se/research/833307/bonesupport-first-impressions-of-q4-report?utm_source=finwire&utm_medium=RSS